The Neuronal Ceroid-Lipofuscinoses
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
The neuronal ceroid-lipofuscinoses (NCLs) collectively constitute the most common group of neurodegenerative diseases in childhood and usually show an autosomal recessive mode of inheritance. Despite varying ages of onset and clinical course characterized in most instances by progressive mental and motor deterioration, blindness, epileptic seizures, and premature death, all forms of NCL show unifying histopathological features. There is accumulation of autofluorescent, periodic acid-Schiff-, and Sudan black B-positive granules that are resistant to lipid solvents in the cytoplasm of most nerve cells and. to a lesser degree, of many other cell types. The storage process is associated with progressive and selective neuronal loss and gliosis with secondary white matter lesions. The ultrastructure of the storage deposits varies between different forms of NCL and, along with the age of onset, has provided the basis for the traditional classification of NCLs. Recent molecular genetic findings have established that defects in at least 7 different genes underlie the various forms of NCL. The purpose of this paper is to provide an overview of the NCLs, review recent molecular genetic and biochemical findings, and discuss their impact on our views on the classification and pathogenesis of these devastating brain disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vesa, J., Hellsten, E., Verkruyse, L. A., Camp, L. A., Rapola, J., Santavuori, P., Hofmann, S. L., & Peltonen, L. (1995) · Nature · doi:10.1038/376584a0 · Cited by 737
Isolation of a novel gene underlying batten disease, CLN3
Lerner, T. J., Boustany, R.-M. N., Anderson, J. W., D'Arigo, K. L., Schlumpf, K., Buckler, A. J., Gusella, J. F., & Haines, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90274-0 · Cited by 601
Sleat, D. E., Donnelly, R. J., Lackland, H., Liu, C.-G., Sohar, I., Pullarkat, R. K., & Lobel, P. (1997) · Science · doi:10.1126/science.277.5333.1802 · Cited by 581
Saftig, P., Hetman, M., Schmahl, W., Weber, K., Heine, L., Mossmann, H., Köster, A., Hess, B., Evers, M., & von Figura, K. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00029.x · Cited by 438
Cathepsin D Deficiency Induces Lysosomal Storage with Ceroid Lipofuscin in Mouse CNS Neurons
Koike, M., Nakanishi, H., Saftig, P., Ezaki, J., Isahara, K., Ohsawa, Y., Schulz-Schaeffer, W., Watanabe, T., Waguri, S., Kametaka, S., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06898.2000 · Cited by 393
Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras.
Camp, L. A., & Hofmann, S. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41567-0 · Cited by 361
Ranta, S., Zhang, Y., Ross, B., Lonka, L., Takkunen, E., Messer, A., Sharp, J., Wheeler, R., Kusumi, K., Mole, S., et al. (1999) · Nature Genetics · doi:10.1038/13868 · Cited by 319
Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice
Gupta, P., Soyombo, A. A., Atashband, A., Wisniewski, K. E., Shelton, J. M., Richardson, J. A., Hammer, R. E., & Hofmann, S. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251485198 · Cited by 305
Savukoski, M., Klockars, T., Holmberg, V., Santavuori, P., Lander, E. S., & Peltonen, L. (1998) · Nature Genetics · doi:10.1038/975 · Cited by 302
NEURONAL CEROID-LIPOFUSCINOSIS (BATTEN'S DISEASE): RELATIONSHIP TO AMAUROTIC FAMILY IDIOCY?
Zeman, W., & Dyken, P. (1969) · Pediatrics · doi:10.1542/peds.44.4.570 · Cited by 272
Tyynelä, J., Sohar, I., Sleat, D. E., Gin, R. M., Donnelly, R. J., Baumann, M., Haltia, M., & Lobel, P. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2786 · Cited by 245
Self-citationInfantile type of so-called neuronal ceroid-lipofuscinosis
Santavuori, P., Haltia, M., Rapola, J., & Raitta, C. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90075-0 · Cited by 244
Self-citationKUFS' DISEASE: A CRITICAL REAPPRAISAL
BERKOVIC, S. F., CARPENTER, S., ANDERMANN, F., ANDERMANN, E., & WOLFE, L. S. (1988) · Brain · doi:10.1093/brain/111.1.27 · Cited by 228
The Neuronal Ceroid-Lipofuscinoses (Batten Disease)
Mole, S. E., & Haltia, M. (2015) · Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease · doi:10.1016/b978-0-12-410529-4.00070-x · Cited by 220
Self-citationGao, H., Boustany, R.-M. N., Espinola, J. A., Cotman, S. L., Srinidhi, L., Antonellis, K. A., Gillis, T., Qin, X., Liu, S., Donahue, L. R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338190 · Cited by 220
Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs)
Holopainen, J. M., Saarikoski, J., Kinnunen, P. K. J., & Järvelä, I. (2001) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02530.x · Cited by 211
Targeted Disruption of the Cln3 Gene Provides a Mouse Model for Batten Disease
Mitchison, H. M., Bernard, D. J., Greene, N. D. E., Cooper, J. D., Junaid, M. A., Pullarkat, R. K., de Vos, N., Breuning, M. H., Owens, J. W., Mobley, W. C., et al. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0267 · Cited by 204
Wheeler, R. B., Sharp, J. D., Schultz, R. A., Joslin, J. M., Williams, R. E., & Mole, S. E. (2002) · The American Journal of Human Genetics · doi:10.1086/338708 · Cited by 199
Biosynthesis and Intracellular Targeting of the CLN3 Protein Defective in Batten Disease
Jarvela, I., Sainio, M., Rantamaki, T., Olkkonen, V. M., Carpen, O., Peltonen, L., & Jalanko, A. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.1.85 · Cited by 192
Sharp, J. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.4.591 · Cited by 190
Storage of saposins A and D in infantile neuronal ceroid‐lipofuscinosis
Tyynelä, J., Palmer, D. N., Baumann, M., & Haltia, M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80908-d · Cited by 188
Self-citationAction of BTN1, the yeast orthologue of the gene mutated in Batten disease
Pearce, D. A., Ferea, T., Nosel, S. A., Das, B., & Sherman, F. (1999) · Nature Genetics · doi:10.1038/8861 · Cited by 180
Sleat, D. E., Gin, R. M., Sohar, I., Wisniewski, K., Sklower-Brooks, S., Pullarkat, R. K., Palmer, D. N., Lerner, T. J., Boustany, R.-M., Uldall, P., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302427 · Cited by 178
Haltia, M., Rapola, J., & Santavuori, P. (1973) · Acta Neuropathologica · doi:10.1007/bf00697751 · Cited by 168
Self-citationBellizzi, J. J., Widom, J., Kemp, C., Lu, J.-Y., Das, A. K., Hofmann, S. L., & Clardy, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080508097 · Cited by 167
Batten disease: Past, present, and future
Rider, J. A., Rider, D. L., Opitz, J. M., Reynolds, J. F., & Pullarkat, R. K. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320310606 · Cited by 156
Fearnley, I. M., Walker, J. E., Martinus, R. D., Jolly, R. D., Kirkland, K. B., Shaw, G. J., & Palmer, D. N. (1990) · Biochemical Journal · doi:10.1042/bj2680751 · Cited by 154
Vines, D. J., & Warburton, M. J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01683-4 · Cited by 154
Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease)
Bronson, R. T., Lake, B. D., Cook, S. A., Taylor, S., & Davisson, M. T. (1993) · Annals of Neurology · doi:10.1002/ana.410330408 · Cited by 154
Luiro, K., Kopra, O., Lehtovirta, M., & Jalanko, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.19.2123 · Cited by 140
Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1
Järvelä, I. E., Schleutker, J., Haataja, L. M., Santavuori, P., Puhakka, L., Manninen, T., Palotie, A. V., Sandkuijl, L. A., Renlund, M., White, R. L., et al. (1991) · Genomics · doi:10.1016/0888-7543(91)90235-7 · Cited by 138
The Human CLN2 Protein/Tripeptidyl-Peptidase I Is a Serine Protease That Autoactivates at Acidic pH
Lin, L., Sohar, I., Lackland, H., & Lobel, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008562200 · Cited by 138
Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9
Bronson, R. T., Donahue, L. R., Johnson, K. R., Tanner, A., Lane, P. W., & Faust, J. R. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980526)77:4<289::aid-ajmg8>3.0.co;2-i · Cited by 137
Lehtovirta, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.1.69 · Cited by 131
Palmer, D. N., Barns, G., Husbands, D. R., & Jolly, R. D. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36006-4 · Cited by 124
The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum
Lonka, L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.11.1691 · Cited by 121
A Variant of Jansky-Bielschowsky Disease
Santavuori, P., Rapola, J., Sainio, K., & Raitta, C. (1982) · Neuropediatrics · doi:10.1055/s-2008-1059612 · Cited by 117
Golabek, A. A., Kida, E., Walus, M., Kaczmarski, W., Michalewski, M. P., & Wisniewski, K. E. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3006 · Cited by 112
Rawlings, N. D., & Barrett, A. J. (1999) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(98)00238-6 · Cited by 108
Apoptosis as the Mechanism of Neurodegeneration in Batten's Disease
Lane, S. C., Jolly, R. D., Schmechel, D. E., Alroy, J., & Boustany, R. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020677.x · Cited by 107
The Spectrum of Jansky-Bielschowsky Disease
Santavuori, P., Rapola, J., Nuutila, A., Raininko, R., Lappi, M., Launes, J., Herva, R., & Sainio, K. (1991) · Neuropediatrics · doi:10.1055/s-2008-1071423 · Cited by 104
Northern Epilepsy: A Novel Form of Neuronal Ceroid‐Lipofuscinosis
Herva, R., Tyynelä, J., Hirvasniemi, A., Syrjäkallio‐Ylitalo, M., & Haltia, M. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00255.x · Cited by 95
Self-citationVariant Late Infantile Neuronal Ceroid-lipofuscinosis: Pathology and Biochemistry
Tyynelä, J., Suopanki, J., Santavuori, P., Baumann, M., & Haltia, M. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199704000-00005 · Cited by 94
Self-citationHirvasniemi, A., Lang, H. N., Lehesjoki, A., & Leisti, J. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.3.177 · Cited by 91
Ezaki, J., Tanida, I., Kanehagi, N., & Kominami, E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722573.x · Cited by 90
Tahvanainen, E., Ranta, S., Hirvasniemi, A., Karila, E., Leisti, J., Sistonen, P., Weissenbach, J., Lehesjoki, A. E., & de la Chapelle, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7267 · Cited by 83
Phenotype–genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5)
Holmberg, V., Lauronen, L., Autti, T. H., Santavuori, P., Savukoski, M., Uvebrant, P., Hofman, I. L., Peltonen, L., & Järvelä, I. E. (2000) · Neurology · doi:10.1212/wnl.55.4.579 · Cited by 82
Claussen, M., Heim, P., Knispel, J., Goebel, H. H., & Kohlschütter, A. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320420422 · Cited by 80
Immunochemical localization of the Batten disease (CLN3) protein in retina.
Katz, M. L., Gao, C., Prabhakaram, M., Shibuya, H., Liu, P. C., & Johnson, G. S. (1997) · PubMed · Cited by 78
1 Neuronal ceroid lipofuscinoses: Classification and diagnosis
Wisniewski, K. E., Kida, E., Golabek, A. A., Kaczmarski, W., Connell, F., & Zhong, N. A. (2001) · Advances in genetics · doi:10.1016/s0065-2660(01)45002-4 · Cited by 78
Expression of Palmitoyl Protein Thioesterase in Neurons
Heinonen, O., Kyttälä, A., Lehmus, E., Paunio, T., Peltonen, L., & Jalanko, A. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.2961 · Cited by 74
Lake, B. D., & Cavanagh, N. P. (1978) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(78)90087-4 · Cited by 73
The Yeast Model for Batten Disease: Mutations in btn1 , btn2 , and hsp30 Alter pH Homeostasis
Chattopadhyay, S., Muzaffar, N. E., Sherman, F., & Pearce, D. A. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.22.6418-6423.2000 · Cited by 72
Messer, A. C., Plummer, J., Maskin, P., Coffin, J. M., & Frankel, W. N. (1992) · Genomics · doi:10.1016/0888-7543(92)90155-l · Cited by 70
Broom, M. F., Zhou, C., Broom, J. E. S., Barwell, K. J., Jolly, R. D., & Hill, D. F. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.9.717 · Cited by 68
Developmental expression of palmitoyl protein thioesterase in normal mice
Isosomppi, J., Heinonen, O., Hiltunen, J. O., Greene, N. D. E., Vesa, J., Uusitalo, A., Mitchison, H. M., Saarma, M., Jalanko, A., & Peltonen, L. (1999) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00115-7 · Cited by 56
Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis
Wisniewski, K. E., Zhong, N. A., Kaczmarski, W., Kaczmarski, A. L., Kida, E., Brown, W. T., Schwarz, K., Lazzarini, A. M., Rubin, A. J., Stenroos, E. S., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430118 · Cited by 55
Klockars, T., Savukoski, M., Isosomppi, J., Laan, M., Järvelä, I. E., Petrukhin, K. E., Palotie, A. V., & Peltonen, L. (1996) · Genomics · doi:10.1006/geno.1996.0324 · Cited by 54
Congenital ceroid-lipofuscinosis
Barohn, R. J., Dowd, D. C., & Kagan‐Hallet, K. S. (1992) · Pediatric Neurology · doi:10.1016/0887-8994(92)90054-3 · Cited by 53
Pathogenesis of brain dysfunction in Batten disease
Walkley, S. U., March, P. A., Schroeder, C. E., Wurzelmann, S., & Jolly, R. D. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320570218 · Cited by 49
Sleat, D. E., Sohár, I., Pullarkat, P. S., Lobel, P., & Pullarkat, R. K. (1998) · Biochemical Journal · doi:10.1042/bj3340547 · Cited by 49
CSF insulin-like growth factor-1 in infantile neuronal ceroid lipofuscinosis
Riikonen, R., Vanhanen, S.-L., Tyynelä, J., Santavuori, P., & Turpeinen, U. (2000) · Neurology · doi:10.1212/wnl.54.9.1828 · Cited by 48
Studies of pH Regulation by Btn1p, the Yeast Homolog of Human Cln3p
Pearce, D. A., Nosel, S. A., & Sherman, F. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2819 · Cited by 47
Adult neuronal ceroid lipofuscinosis
INSERM (2020) · Definitions · doi:10.32388/i7l2vd · Cited by 46
Elleder, M., Franc, J., Kraus, J., Nevšímalová, S., Sixtová, K., & Zeman, J. (1997) · European Journal of Paediatric Neurology · doi:10.1016/s1090-3798(97)80041-4 · Cited by 42
Wisniewski, K. E., Maślińska, D., Kitaguchi, T., Kim, K. S., Goebel, H. H., & Haltia, M. (1990) · Acta Neuropathologica · doi:10.1007/bf00294218 · Cited by 40
Self-citationNorthern epilepsy syndrome: clinical course and the effect of medication on seizures
Hirvasniemi, A., Herrala, P., & Leisti, J. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01616.x · Cited by 39
Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipoluscinosis
Zhong, N., Krystyna, Wisniewski, É., Hartikainen, J. M., Ju, W., Moroziewicz, D. N., McLendon, L., Brooks, S. S., & Brown, W. T. (1998) · Clinical Genetics · doi:10.1111/j.1399-0004.1998.tb04291.x · Cited by 38
An animal model of the infantile type of neuronal ceroid‐lipofuscinosis
Järplid, B., & Haltia, M. (1993) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00710263 · Cited by 34
Self-citationA Murine Model for Juvenile NCL: Gene Targeting of MouseCln3
Greene, N. D. E., Bernard, D. L., Taschner, P. E. M., Lake, B. D., Vos, N. D., Breuning, M. H., Gardiner, R. M., Mole, S., Nussbaum, R. L., & Mitchison, H. M. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2828 · Cited by 32
Neuronal Ceroid Lipofuscinoses and Possible Pathogenic Mechanism
Zhong, N. A. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3057 · Cited by 28
Sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses: an immunological study
Tyynel�, J., Baumann, M., Henseler, M., Sandhoff, K., & Haltia, M. (1995) · Acta Neuropathologica · doi:10.1007/bf00307641 · Cited by 28
Self-citationCONGENITAL NEURONAL CEROID LIPOFUSCINOSIS A Case Report
GARBORG, I., TORVIK, A., Hals, J., Tangsrud, S. E., & Lindemann, R. (1987) · Acta Pathologica Microbiologica Scandinavica Series A Pathology · doi:10.1111/j.1699-0463.1987.tb00017_95a.x · Cited by 24
Congenital neuronal ceroid lipofuscinosis
INSERM (2020) · Definitions · doi:10.32388/vmasx6 · Cited by 22
Infantile Type of So-Called Neuronal Ceroid-Lipofuscinosis
Santavuori, P., Haltia, M., Rapola, J., et al. (1974) · Acta geneticae medicae et gemellologiae · doi:10.1017/s1120962300023763 · Cited by 10
Self-citationIncidence of neuronal perikaryal spheroids in neuronal ceroid lipofuscinoses (Batten disease).
Elleder, M., & Tyynelä, J. (1998) · PubMed · Cited by 8
Cited by
Worgall, S., Sondhi, D., Hackett, N. R., Kosofsky, B., Kekatpure, M. V., Neyzi, N., Dyke, J. P., Ballon, D., Heier, L., Greenwald, B. M., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.022 · Cited by 402
Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis
Siintola, E. (2006) · Brain · doi:10.1093/brain/awl107 · Cited by 389
Neuronal ceroid lipofuscinoses
Jalanko, A., & Braulke, T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.004 · Cited by 339
Kousi, M., Lehesjoki, A.-E., & Mole, S. E. (2012) · Human Mutation · doi:10.1002/humu.21624 · Cited by 332
Koike, M., Shibata, M., Waguri, S., Yoshimura, K., Tanida, I., Kominami, E., Gotow, T., Peters, C., von Figura, K., Mizushima, N., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61253-9 · Cited by 330
Metadata
- Authors
- Haltia, M.
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01
- Volume
- 62
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W32417562
- Cited by
- 353
- References
- 76
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.